3184.0 Genetic/Molecular and Pharmacological Epidemiology Poster Session

Monday, October 29, 2012: 12:30 PM - 1:30 PM

Board 2
Can pharmacy chronic disease screening services reach high-risk, vulnerable populations?
Crystal Fuller, PhD, MPH, Preston Garnes, Natalie Crawford, PhD, Alexis Rivera, MPH, Silvia Amesty, MD, MPH, MSEd, Alezandria Turner, PhD and Katherine Harripersaud, MPH
Board 3
Effect of long acting beta agonist therapy on risk of hospitalization in new start COPD patients
Flavia Ejzykowicz, MS, Krithika Rajagopalan, PhD, Vamsi Bollu, PhD MBA, John Karafilidis, PharmD and Joel Hay, PhD
Board 4
Association of Commonly Used Medications with Prevalence and Renal Recovery after Postoperative Acute Kidney Injury
Shahab Bozorgmehri, MD, MPH, CPH, Meghan Brennan, MS, Tezcan Ozrazgat Baslanti, PhD, Charles E. Hobson, MD, MHA and Azra Bihorac, MD, MS, FASN
Board 5
Provider Characteristics Influencing the Prescription of Antidepressants without a Psychiatric Diagnosis in the United States, 2006-2009
Brandy Marriner, PharmD, MSCR candidate, Wesley Rich, PhD, Allison Matthews, MSCR, Ryan Hall, MD and Tina Tseng, PhD, MSPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Epidemiology

See more of: Epidemiology